Selpercatinib plus cemiplimab in <i>RET</i> positive medullary thyroid cancer patient with skin cancers

Authors

Institutions

Publication Details

Journal
Tumori Journal
Published
2025-11-09
DOI
https://doi.org/10.1177/03008916251378278
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers

Alfredo Berruti, Laura D. Locati, Vito Amoroso, Francesca Puce et al.
Tumori Journal
Thyroid Cancer Diagnosis and Treatment
article

Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers

Alfredo Berruti, Laura D. Locati, Vito Amoroso, Francesca Puce, Federico Sottotetti
article en

Abstract

No abstract available for this paper.
Tumori JournalVol. 111(6)
University of Pavia (IT), Istituti Clinici Scientifici Maugeri (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), University of Brescia (IT)
Openalex Percentile: Top 55%
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.